Pyxis Oncology Inc
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
(0.0% 1d) (23.3% 1m) (49.0% 1y) (0.0% 2d) (-0.7% 3d) (8.2% 7d) (-18.32% volume)
Earnings Calendar: 2023-11-01
Market Cap: $ 258,402,852
https://pyxisoncology.com
Sec Filling | Patents | 2021 employees
Pyxis Oncology, Inc. is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis develops its product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Since its launch in 2019, Pyxis has developed a broad portfolio of novel antibody drug conjugate, or ADC, product candidates, and monoclonal antibody, or mAb, preclinical discovery programs that it is developing as monotherapies and in combination with other therapies.
cancer t-cell
add to watch list Paper trade email alert is off
Press-releases
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-03-28 (Crawled : 21:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
nasdaq grants
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: -7.92%
H: 4.0%
C: -0.8%
year update financial results
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
Published: 2024-03-13 (Crawled : 12:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: -1.23%
H: 9.06%
C: -4.97%
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
Published: 2024-03-07 (Crawled : 22:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: -0.48%
H: 1.13%
C: -9.19%
conference biopharma global
Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 3.57%
C: -2.64%
pyx-201 pyx-106 preclinical meeting
Pyxis Oncology Announces $50 Million Private Placement
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: 23.01%
H: 16.5%
C: 8.33%
million
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-12-29 (Crawled : 22:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
nasdaq grants
Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: -1.94%
H: 3.29%
C: -0.66%
medical
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
Published: 2023-11-07 (Crawled : 21:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: -1.81%
update financial results
Inspiring the Next Generation of Entrepreneurs at the Diversity and Equity Accelerator through Learning for Startups (DEALS) Workshop
Published: 2023-10-23 (Crawled : 15:30) - prnewswire.com
PYXS | $4.445 -1.22% -1.24% 230K
|
Professional, Scientific, and T...
|
| O: -3.05%
H: 6.92%
C: 0.63%
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0000950170-24-030865 | 4 | 2024-03-13 | 2024-03-12 | Buy | A | 69760 | 69760 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10